SB-236057
SB-236057
SB-236057 (/ˈɛsˈbiːˈtuːˈθriːˈsɪksˈoʊˈfaɪvˈsɛvən/) is a pharmacological compound that is often used in scientific research.
Etymology
The name "SB-236057" is derived from the initials of the pharmaceutical company that first synthesized the compound, followed by a unique numerical identifier. The exact etymology of the name is not publicly disclosed.
Description
SB-236057 is a potent and selective 5-HT1B receptor antagonist. It is often used in research to study the role of 5-HT1B receptors in various physiological and pathological processes. The compound has a high affinity for 5-HT1B receptors and a much lower affinity for other serotonin receptor subtypes.
Related Terms
- 5-HT1B receptor: A subtype of serotonin receptor that SB-236057 specifically targets.
- Serotonin receptor: A broad class of receptors that SB-236057 belongs to.
- Antagonist: A type of pharmacological agent that SB-236057 is classified as.
- Pharmacology: The scientific field that studies compounds like SB-236057.
See Also
External links
- Medical encyclopedia article on SB-236057
- Wikipedia's article - SB-236057
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski